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In this issue, Garcia-Bassets et al. (2007) show that spurious transcriptional activation by 
unliganded nuclear receptors is inhibited by histone lysine methylation. This inhibitory 
histone modification code is efficiently countered by the ligand-dependent recruitment of 
histone lysine demethylases, including lysine-specific demethylase 1 (LSD1), which appear 
to be used for this purpose by a number of signal-regulated transcriptional activators.Chromatin—the physiological sub-
strate for DNA-mediated enzymatic 
processes in the nucleus—is a plat-
form that instills stringent regula-
tion on nuclear processes, such as 
transcription. Much of the regulation 
imposed by chromatin is achieved 
through the histone code—myriad 
covalent modifications placed on 
histones at particular loci to specify 
a functional outcome (Jenuwein and 
Allis, 2001). A theme of the histone 
code is that specific histone modifi-
cations are determined by local lev-
els and activities of opposing enzyme 
pairs such as histone acetyltrans-
ferases and histone deacetylases 
(Jenuwein and Allis, 2001). Even his-
tone methylation, which was thought 
to be an irreversible epigenetic mark, 
can be reversed by histone demeth-
ylases, including lysine-specific 
demethylase 1 (LSD1) and a family 
of JmjC domain-containing histone 
demethylases (such as JMJD1A) 
(Shi and Whetstine, 2007). LSD1 was 
originally identified as a component 
of the CoREST corepressor complex 
and, in this context, it demethylates 
dimethyl lysine 4 of histone H3 (H3-
K4me2) in vitro (Lee et al., 2005; Shi 
et al., 2005). H3-K4me2 is associ-
ated with an activated transcriptional 
state and, therefore, demethylation 
of this mark by LSD1 is associated 
with repression of CoREST target 
genes (Shi et al., 2004). In addition 
to its role as a corepressor, LSD1 
is also a coactivator of the andro-
gen receptor, where its presence at 
target promoters in cells correlates 
with the demethylation of H3-K9me2 (Metzger et al., 2005). H3-K9me2 is 
associated with repressed genes, 
and, thus, its demethylation corre-
lates with a positive effect on tar-
get gene transcription (Daniel et al., 
2005; Shi and Whetstine, 2007).
In this issue, Garcia-Bassets et al. 
(2007) examine the role of histone 
lysine methylation, a cohort of his-
tone methyltransferases, and LSD1 
in establishing ligand dependency for 
gene activation by estrogen recep-
tor α (ERα). Their starting point was 
a seemingly simple question: what 
sites does LSD1 bind to in ERα-posi-
tive MCF-7 human breast-cancer cells 
treated with estradiol? The answer 
they obtained was surprising.
For their LSD1 genomic localiza-
tion studies, Garcia-Bassets et al. 
(2007) used a variation of genome-
wide chromatin immunoprecipitation 
(ChIP) called ChIP-DSL (DNA selec-
tion and ligation). ChIP-DSL is more 
sensitive than conventional ChIP-
chip technology, yielding an impres-
sive number of binding targets (see 
below), but, due to practical con-
siderations, is also likely to have a 
more limited resolution for determin-
ing precise genomic localization. 
With ChIP-DSL, crosslinked and 
immunoprecipitated genomic DNA 
serves as a template to direct the 
precise sequence-specific ligation 
of a library of 20-mer oligonucleotide 
pairs. The ligated oligonucleotide 
library is amplified, labeled, and 
used to hybridize a DNA microarray 
containing spotted 40-mer probes 
corresponding to each possible 
correctly ligated 20-mer pair in the Cell 128, Flibrary. A signal for a specific probe 
on the microarray requires the pres-
ence of the corresponding target in 
the immunoprecipitated genomic 
DNA (Kwon et al., 2007).
Using ChIP-DSL, the authors 
found that ?4,200 out of the 
?20,000 promoters they queried 
were occupied by LSD1. Further-
more, ?80% of the LSD1-positive 
promoters were also occupied by 
RNA polymerase II, with the corre-
sponding genes showing detecta-
ble expression. In total, the authors 
found more active genes associ-
ated with LSD1 than inactive genes 
by a ratio of 4:1. Thus, in addition 
to its previously characterized role 
in transcriptional repression (Shi 
and Whetstine, 2007), LSD1 has an 
even broader role in transcriptional 
activation. In additional ChIP-DSL 
experiments (Kwon et al., 2007), 
the authors identified ?580 ERα-
positive promoters in the pres-
ence of estradiol (compared to 153 
ERα-positive promoters identified 
in a previous study using conven-
tional ChIP-chip technology with 
an ?18,700 human promoter array 
[Laganiere et al., 2005]). Of the 
?580 ERα-positive promoters, 
?60% were LSD1-positive as well, 
suggesting a surprisingly broad 
requirement for LSD1 at estrogen-
regulated promoters.
To explore the role of LSD1 in 
ERα-mediated gene expression in 
more detail, the authors performed 
a variety of cell-based gene-specific 
assays. RNAi-mediated knockdown of 
LSD1 was shown to inhibit estradiol-ebruary 9, 2007 ©2007 Elsevier Inc. 433
dependent expression of LSD1-posi-
tive (e.g., TFF1 and GREB1), but not 
LSD1-negative (e.g., WISP), ERα tar-
get genes. In complementation stud-
ies, wild-type, but not enzymatically 
inactive LSD1, was able to restore 
estradiol-dependent expression of 
the LSD1-positive genes. Interest-
ingly, a reduction in both H3-K4me2 
and H3-K9me2 was observed con-
comitant with the estradiol-depend-
ent recruitment of ERα and LSD1 to 
these target genes. Together, these 
assays indicate a key role for LSD1 in 
the estradiol-dependent expression of 
ERα target genes.
Next, the authors examined the 
role of histone methyltransferases 
that lay down the methylated histone 
marks. Although RNAi-mediated 
depletion of known H3-K4 histone 
methyltransferases (e.g., MLL1) had 
little effect on the basal expression 
of TFF1 and GREB1, depletion of 
several H3-K9 histone methyltrans-
ferases (e.g., RIZ1, ESET, and Eu-
HMTase1) derepressed the promot-
ers. This occurred in the absence 
of ligand but was dependent on the 
recruitment of unliganded ERα to the 
promoters. As expected, in unma-
nipulated cells, the binding of ESET 
and RIZ1 at the TFF1 and GREB1 
promoters was reduced upon treat-
ment with estradiol, corresponding 
to the reduction in H3 methylation 
and recruitment of ERα and LSD1 
noted above.
Collectively, the results presented 
by Garcia-Bassets et al. (2007) sug-
gest a carefully orchestrated mecha-
nism for preventing spurious tran-
scriptional activation by unliganded 
nuclear receptors and allowing 
appropriate activation in the presence 
of ligand. The mechanism involves (1) 
the establishment of inhibitory histone 
methylation marks by specific histone 
methyltransferases, which act to keep 
target promoters repressed in the 
absence of ligand in part by blocking 
the binding of unliganded receptor 
(a “gatekeeper” function) and (2) the 
reversal of these inhibitory marks by 
the ligand-dependent recruitment of 
LSD1 to DNA bound receptor. These 
histone-modifying enzymes appear to 
play a similar role for other signal-reg-434 Cell 128, February 9, 2007 ©2007 Elulated transcription systems (such as 
those controlled by androgen recep-
tor, retinoic acid receptor β, NF-κB, 
and AP-1). Interestingly, LSD1-nega-
tive estradiol-regulated genes, such 
as WISP2, use a similar mechanism, 
but with a different histone methyl-
transferase/histone demethylase pair 
(i.e., G9a and JMJD1A). Thus, this 
mode of regulation is likely to repre-
sent a fundamental mechanism con-
trolling the regulation of a wide array 
of signal-regulated genes.
Most prior studies of LSD1 have 
examined its role as an H3-K4me2 
demethylating corepressor (Shi and 
Whetstine, 2007). The results from 
Garcia-Bassets et al. (2007) indicat-
ing a broad role for LSD1 in coun-
teracting the repressive effects of 
H3-K9 histone methyltransferases 
pose several important mechanistic 
questions. For example, how is the 
substrate specificity of LSD1 altered 
from that of an H3-K4 demethylase 
at negatively regulated CoREST tar-
get genes to an H3-K9 demethylase 
at positively regulated LSD1 target 
genes? Perhaps an LSD1-interacting 
coregulator, the transcription factors 
that recruit LSD1, or other localized 
histone marks allosterically mod-
ify the substrate specificity of the 
enzyme, as suggested by previous 
studies (Lee et al., 2005; Metzger et 
al., 2005; Shi and Whetstine, 2007; 
Shi et al., 2005).
Additionally, what is the mecha-
nism by which the H3-K9me2 mark 
is transduced into a signal that pre-
vents the inappropriate activation of 
transcriptional targets by unstimu-
lated transcription factors? Acetyla-
tion and methylation of a particular 
lysine are mutually exclusive (Jenu-
wein and Allis, 2001). Perhaps the 
role of H3-K9me2 in transcriptional 
repression is a manifestation of a 
crucial positive role of H3-K9 acetyla-
tion in signal-regulated transcription. 
Or, perhaps H3-K9me2 serves as a 
binding platform for a corepressive 
effector protein, such as heterochro-
matin protein 1 (HP1). HP1, known 
to bind the heterochromatin-spe-
cific mark H3-K9me3, has also been 
shown to associate with H3-K9me2, 
a mark specifically involved in the sevier Inc.repression of euchromatic genes 
(Daniel et al., 2005). Alternatively, 
demethylation of nonhistone targets 
(e.g., transcription factors or coreg-
ulators) by LSD1 may be the actual 
activating signal or function as an 
alternate signal. Proving a causative 
role for a particular histone modifi-
cation is a difficult task. A promising 
approach is the use of in vitro chro-
matin assembly and transcription 
systems together containing mutant 
or uniformly modified histones (An 
et al., 2004). Such an approach will 
be instrumental in addressing these 
questions.
Although many questions remain, 
there is little doubt that the results 
from Garcia-Bassets et al. (2007) 
represent a large step forward in 
our understanding of how opposing 
enzyme pairs work together to pro-
vide stringent regulation of signal-
regulated transcription.
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